Gout as a cardiovascular risk factor
Keywords:
cardiovascular disease, rheumatic disease, gout, arterial hypertensionAbstract
Introduction: Gout is a chronic inflammatory disease that generally progresses with added hyperuricemia.
Objective: To identify the presence of cardiovascular involvement in patients with a confirmed diagnosis of gouty arthropathy.
Methodology: A basic, non-experimental, descriptive, retrospective and mixed-focus research was developed. The universe consisted of 69 patients treated in first-level health care units in the city of Riobamba during the period between January 2019 and January 2021. The sample was made up of a total of 60 patients. A review of the clinical history of the patients was carried out to obtain the necessary information.
Result: Average age of 53.02 years. 35.00% of them presented at least one associated comorbidity, where diabetes mellitus was the most represented (57.14%). with presence of comorbidities. 71.67% of the patients had normal blood uric acid values at the time of diagnosis and 18.33% had some type of kidney damage. 36.67% of the patients with gout also presented cardiovascular disease, where arterial hypertension (59.09% was the most frequently reported.
Conclusions: Gouty arthropathy is a disease that theoretically generates a high percentage of cardiovascular diseases within of which arterial hypertension and heart failure stand out.
Downloads
References
- Solis Cartas U, Bejarano S, Valdés González JL, Aguirre Saimeda GL. Necrosis avascular de la cabeza femoral en un paciente con gota. Rev Cuba Reumatol [Internet]. 2018 [citado 2021 May 28];20(2): e14. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000200009&lng=es
- Ortiz Olivares Ana Maria, Cortés Ross Odisa Mildres, Torres Motas Deisy de los Milagros. Chronic tophaceous gout in an adult. MEDISAN [Internet]. 2019 [citado 2021 May 25];23(1):114-20. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192019000100114&lng=es
- Machado Curbelo AJ, Amaro Méndez S. Gota, hiperuricemia e hiperlipoproteinemias. Rev Cubana Med [Internet]. 2020 [citado 2021 Jun 01;16(4):[aprox. 7 p.]. Disponible en: http://www.revmedicina.sld.cu/index.php/med/article/view/1130
- Valdés González JL, Valdés González EM, Solis Cartas U, Sigcho Romero SF. Dengue, COVID-19 y gota, una asociación infrecuente. Rev Cubana de Reumatolo [Internet]. 2020 [citado 2021 May 30];22(4 Extra.):[aprox. 9 p.]. Disponible en: http://revreumatologia.sld.cu/index.php/reumatologia/article/view/871
- Santillana-Marín RA, Múzquiz-Ramos EM, García-Cerda LA, Cruz-Ortíz BR. (2018). Bioactividad y pruebas de hemólisis de compósitos de hidroxiapatita zirconia (HAp/ZrO2-8Y2O3) para implantes óseos. Revista mexicana de ingeniería biomédica, [Internet]. 2020 [citado 2021 May 31]: 39(3):262-70. Disponible en: https://doi.org/10.17488/rmib.39.3.5
- Valdés González JL, Paca Gualla MJ, González Benitez S, Freire Ramos ER. Patrón nutricional en pacientes con gota. Rev Cuba Reumatol [Internet]. 2020 Dic [citado 2021 May 26];22(3): e780. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962020000300003&lng=es
- Chapalbay Parreño IC, Ayala Reinoso PP, Campos Ruiz LF, Orna Brito VH, Martínez Larrarte JP. Adherencia farmacológica en pacientes con enfermedades reumáticas. Rev Cuba Reumatol [Internet]. 2019 [citado 2021 Jun 03];21(3): e99. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962019000300003&lng=es
- Vázquez Ávila JA, Zetina Martínez M, Duarte Mote J. Hiperuricemia e hipertensión arterial sistémica: ¿cuál es la relación?. Med. interna Méx. [Internet]. 2018[citado 2021 May 29];34(2): 278-87. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662018000200009&lng=es
- Lombas García M, Giral Casielles R, Mateo Suárez M, Moreno Mejías A, Castell Pérez C. Concepto, clasificación, diagnóstico y tratamiento de las artropatías. Rev Cubana Med [Internet]. 2009 [citado 2021 Jun 6];13(6):[aprox. 8 p.]. Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/368
- Vizcaino Luna Y, Bermúdez Marrero WM, Bermúdez Marrero WA, Egües Mesa JL, Cárdenas Domínguez T, Prendes García E. Gout Arthritis. Ten years of follow up. Rev Cubana de Reumatolo [Internet]. 2019 [citado 02 Jun 2021];21(3):[aprox. 0 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/717
- López-Rocha EG, Hernández-Montoya G, Rodríguez-Pesina AH, Rodríguez-Mireles KA. Desensibilización a alopurinol en paciente con gota tofácea. Rev. alerg. Méx.[Internet]. 2018[citado 2021 Jun 02];65(3):316-20. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2448-91902018000300236&lng=es
- Leal Balón E, Arjona Rodríguez IA, Quiñones Milián IR, Massip Nicot J, Goberna Rocha M, Fernández Massip H. Perfil clínico y terapéutico en insuficiencia cardiaca aguda. Arch. Hosp. Univ. "Gen. Calixto García” [Internet]. 2020 [citado 2021 Jun 03];8(3):[aprox. 7 p.]. Disponible en: http://revcalixto.sld.cu/index.php/ahcg/article/view/536
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
